- Poster presentation
- Open Access
Accelerated whole-heart 3D CSPAMM reveals impact of beta-blocker therapy on myocardial architecture
- Boris Schmitt1
© Schmitt; licensee BioMed Central Ltd. 2010
Published: 21 January 2010
Myocardial tagging using accelerated whole-heart 3D CSPAMM is a tool to study myocardial wall motion parameters like strain, shortening and rotation.
Wall motion is altered in many heart diseases leading to heart failure.
One main column in therapy is beta-blockers while its physical mechanisms are not entirely understood yet.
Differences in beta-blocker sensitivity of longitudinal and transverse myocardial fibres seem to be of relevance.
We postulate a positive effect of early blocking of the contraction of the transverse myocardial fibres at low beta-blocker dosages which leads to increased longitudinal contractility with consecutively enhanced myocardial function.
MRI 3D-tagging is used to investigate the structural basic principle in myocardial architecture accounting for the effect of beta-blocker therapy in myocardial insufficiency.
We included 10 healthy adults and administered an infusion of the beta-blocker Esmolol at increasing dosages starting from 5 or 50 μg/kg/min to 150 μg/kg/min.
Using a 3 T Philips Archieva® R2.5.3 MRI and the Gyrotools® 3D-tagging software we performed a whole-heart tagging scan with grid line interspace of 7 mm at each dosage.
In addition short axis CINE scans were performed to capture changes in systolic and diastolic ventricular volumes and stroke volumes respectively.
Stroke volumes were verified by executing phase-contrast MRI flow measurements in the ascending aorta.
During the MRI investigation ECG and blood pressure were continuously monitored.
After 3D shift correction the tagging scans were evaluated using TagTrack 1.5.2®.
In short axis views midventricular contours were drawn and processed throughout all heart phases, results exported as numeric values for circumferential and radial shortening [%] and rotation [degrees] and displayed as curves over time [heart phases].
In six volunteers a shift of shortening curves towards earlier heart phases (left-shift) and a decrease in the area-under-the-curve (work) was noted. In three volunteers no significant change in phase but decrease in amplitude and work was observed. One proband showed a significant right-shift (negative inotropy) from the start. This proband was investigated a second time starting at a very low dose of 5 μg/kg/min resulting in a left-shift up to 25 μg/kg/min and a reproducible right-shift from 50 to 150 μg/kg/min. Vital parameters remained stable at all dosages in all volunteers.
Beta-blockers at low doses evoke an accelerated contraction profile leading to less myocardial work load with prolonged rest at diastole. At higher doses they induce negative inotropy. Individual beta-blocker-sensitivity can be detected by MRI 3D-tagging.
This article is published under license to BioMed Central Ltd.